Maprotiline is a tricyclic antidepressant used to treat depression. During the manufacturing process, impurities can be formed which may affect the purity and potency of the drug. Maprotiline impurities can include degradation products, residual solvents, and other related substances. These impurities need to be identified and controlled to ensure the safety and efficacy of the drug product. Analytical methods are used to detect and quantify these impurities to establish appropriate limits for their presence in the drug product.
